HRT Financial’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

HRT Financial’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-85,412	Closed	-$866K	–	3769
2022 Q3	$866K	Hold	85,412	–	–	0.01%	1031
2022 Q2	$843K	Hold	85,412	–	–	0.01%	1063
2022 Q1	$853K	Hold	85,412	–	–	0.01%	1184
2021 Q4	$849K	Hold	85,412	–	–	﹤0.01%	1272
2021 Q3	$856K	Hold	85,412	–	–	0.01%	1467
2021 Q2	$860K	Sell	85,412 -9,053	-10%	-$91.7K	0.01%	1232
2021 Q1	$964K	Buy	94,465 +11,749	+14%	+$125K	0.01%	1208
2020 Q4	$861K	Buy	+82,716	New	+$863K	0.02%	753

HRT Financial's FLACU Position: Q4 2022 in Review

HRT Financial sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 85,412 shares — an estimated $866K sold.

HRT Financial first reported a position in FLACU in Q4 2020 and held it in 8 quarters. The position peaked at $964K in Q1 2021. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

HRT Financial reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
HRT Financial sold 85,412 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2022, an estimated $866K.
HRT Financial first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 8 quarters.
HRT Financial's Frazier Lifesciences Acquisition Corporation Unit position peaked at $964K in Q1 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.